These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11086711)
1. Some oncogene and tumour suppressor gene protein products expression in B-cell chronic lymphocytic leukaemia. Niewiadomska H; Mirowski M; Kulczycka D; Najder M; Balcerczak E; Błoński JZ Cytobios; 2000; 103(404):159-68. PubMed ID: 11086711 [TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586 [TBL] [Abstract][Full Text] [Related]
3. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease. Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
5. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
6. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061 [TBL] [Abstract][Full Text] [Related]
7. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
8. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53. Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690 [TBL] [Abstract][Full Text] [Related]
9. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients. Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768 [TBL] [Abstract][Full Text] [Related]
10. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777 [TBL] [Abstract][Full Text] [Related]
11. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Lumachi F; Ermani M; Marino F; Iacobone M; Baldessin M; Cappuzzo G; Zanella S; Favia G Anticancer Res; 2006; 26(2A):1305-8. PubMed ID: 16619538 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma. Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011 [TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
14. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Faderl S; Keating MJ; Do KA; Liang SY; Kantarjian HM; O'Brien S; Garcia-Manero G; Manshouri T; Albitar M Leukemia; 2002 Jun; 16(6):1045-52. PubMed ID: 12040436 [TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
19. [Expression of bcl-2, Ki-67 and p-53 in uveal melanomas]. Krvavica A; Talan-Hranilović J; Belicza M Acta Med Croatica; 2008 Jul; 62(3):267-71. PubMed ID: 18843846 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma. Mateoiu C; Pirici A; Bogdan F Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]